In conditions such as diabetes, for example, the laboratory measurement of HgbA1c is a benchmark; in hypertension, the benchmark is a vital sign; in acute stroke care, the benchmarks include door-to-imaging time and administration of tPA; in neurologic conditions such as dementia and TBI, the benchmarks are the results of standardized clinician-administered cognitive testing, etcetera. Here, PLAT is linked to hypertensive disorder.